RECRUITING

Cryopreservation of Ovarian Tissue

Talk to us

Conditions

CancerRisk of Premature Ovarian FailureFertility PreservationOvarian tissue cryopreservationOvarian tissue transplantation

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.

Official Title

Cryopreservation of Ovarian Tissue for Potential In Vitro Maturation or Autologous Transplantation

Quick Facts

Study Start:1997-04
Study Completion:2025-10-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT01558544

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Females 0-45 years of age who are premenopausal
  2. * Treatment plan that will likely result in premature menopause or premature ovarian failure
  3. * This includes patients receiving:
  4. * Cancer treatment with abdominal pelvic irradiation and/or high dose chemotherapy
  5. * Surgery that requires removal of ovaries for medical condition or disease, e.g. Prophylactic oophorectomy in BRCA patients
  6. * Patient is unable or unwilling to pursue fertility preservation by freezing oocytes or embryos.
  7. * Previous treatment for cancer is acceptable if patient still has ovarian function
  8. * Patient is medically stable enough to undergo surgery (cleared for anesthesia)
  1. * Patients not meeting the above criteria
  2. * Patients who have not received medical clearance from their physicians to undergo surgery
  3. * Patients already experiencing menopause.

Contacts and Locations

Study Contact

Rodriq E. Stubbs, NP
CONTACT
646-962-3276
res2011@med.cornell.edu

Principal Investigator

Glenn Schattman, MD
PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University

Study Locations (Sites)

Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine
New York, New York, 10021
United States

Collaborators and Investigators

Sponsor: Weill Medical College of Cornell University

  • Glenn Schattman, MD, PRINCIPAL_INVESTIGATOR, Weill Medical College of Cornell University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date1997-04
Study Completion Date2025-10-31

Study Record Updates

Study Start Date1997-04
Study Completion Date2025-10-31

Terms related to this study

Keywords Provided by Researchers

  • Ovarian tissue cryopreservation
  • Ovarian tissue transplantation
  • Fertility preservation
  • Risk of premature ovarian failure

Additional Relevant MeSH Terms

  • Cancer
  • Risk of Premature Ovarian Failure
  • Fertility Preservation